StephenCKoehlerMD

Oncology • South Pasadena, CA

Director the Oncology unit at Huntington Hospital; Physician at City of Hope and the City of Hope

Join to view full profile

Are you Dr. Koehler?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
You already have 86 invites waiting!
Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

Office
209 Fair Oaks Ave
South Pasadena, CA 91030
Phone+1 626-396-2900

Fax+1 626-396-2911

Summary

Dr. Stephen Koehler, MD is an oncologist in South Pasadena, California. He is currently licensed to practice medicine in California. He is affiliated with Huntington Health, USC Arcadia Hospital, and City of Hope Comprehensive Cancer Center.

Education & Training

City of Hope National Medical CenterFellowship, Hematology and Medical Oncology, 1980 - 1981
University of Southern California/LAC+USC Medical CenterFellowship, Hematology, 1978 - 1980
University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Internal Medicine, 1974 - 1978
University of California, Irvine, School of MedicineClass of 1974

Certifications & Licensure

CA State Medical License 1975 - 2026
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012
Top MD Consumers Checkbook

Clinical Trials

Eribulin Mesylate in Treating Patients With Locally Advanced or Metastatic Cancer of the Urothelium and Kidney Dysfunction Start of enrollment: 2006 Oct 23
Active, not recruiting
Phase 1, Phase 2
Vorinostat and Rituximab in Treating Patients With Indolent Non-Hodgkin Lymphoma Start of enrollment: 2008 Jul 23
Completed
Phase 2
Acupuncture in Treating Nerve Pain in Patients With Stage I, Stage II, or Stage III Breast Cancer Who Are Receiving Paclitaxel Start of enrollment: 2010 Jan 01
Terminated
Not Applicable
Cediranib Maleate With or Without Lenalidomide for the Treatment of Thyroid Cancer Start of enrollment: 2010 Sep 09
Completed
Phase 1, Phase 2
Everolimus and Combination Chemotherapy in Treating Patients With Metastatic Stomach or Esophageal Cancer Start of enrollment: 2012 Feb 01
Completed
Phase 1, Phase 2
Aldesleukin With or Without Ziv-Aflibercept in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery Start of enrollment: 2011 Jan 18
Completed
Phase 2
Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction Start of enrollment: 2011 Jun 20
Active, not recruiting
Phase 1
Nab-Paclitaxel in Treating Older Patients With Locally Advanced or Metastatic Breast Cancer Start of enrollment: 2012 Jun 19
Active, not recruiting
Phase 2
Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Locally Advanced or Inflammatory Triple Negative Breast Cancer Start of enrollment: 2012 Feb 15
Active, not recruiting
Phase 2
Abiraterone Acetate and Prednisone With or Without Veliparib in Treating Patients With Metastatic Castration-Resistant Prostate Cancer Start of enrollment: 2012 Mar 30
Completed
Phase 2
Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction Start of enrollment: 2012 Jun 12
Active, not recruiting
Phase 1
Tivantinib and Topotecan Hydrochloride in Treating Patients With Advanced or Metastatic Solid Tumors Start of enrollment: 2012 Jul 24
Completed
Phase 1
Trebananib With or Without Bevacizumab, Pazopanib Hydrochloride, Sorafenib Tosylate, or Sunitinib Malate in Treating Patients With Advanced Kidney Cancer Start of enrollment: 2012 Aug 01
Completed
Phase 2
Ipilimumab in Treating Patients With Metastatic or Recurrent Human Papilloma Virus-Related Cervical Cancer Start of enrollment: 2012 Dec 03
Completed
Phase 2
Cetuximab With or Without Tivantinib in Treating Patients With Head and Neck Cancer That Is Recurrent, Metastatic, or Cannot Be Removed by Surgery Start of enrollment: 2012 Aug 20
Completed
Phase 2
Ipilimumab and Rituximab in Treating Patients With Relapsed or Refractory B-cell Lymphoma Start of enrollment: 2012 Nov 19
Completed
Phase 1
Pertuzumab, Trastuzumab, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With HER2-Positive Advanced Breast Cancer Start of enrollment: 2013 Jul 17
Active, not recruiting
Phase 2
Sipuleucel-T With or Without Radiation Therapy in Treating Patients With Hormone-Resistant Metastatic Prostate Cancer Start of enrollment: 2013 Jun 07
Completed
Phase 2
Dabrafenib in Treating Patients With Solid Tumors and Kidney or Liver Dysfunction Start of enrollment: 2013 Aug 23
Terminated
Phase 1
Cabozantinib S-Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer Start of enrollment: 2013 Apr 29
Active, not recruiting
Phase 2
Trametinib in Treating Patients With Advanced Cancer With or Without Hepatic Dysfunction Start of enrollment: 2014 Mar 10
Active, not recruiting
Phase 1
Gemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Start of enrollment: 2014 Jul 21
Active, not recruiting
Phase 2
Join now to see all

Publications & Presentations

PubMed

14 citations
Intravenous 5-fluoro-2′-deoxycytidine administered with tetrahydrouridine increases the proportion of p16-expressing circulating tumor cells in patients with advanced ...
Geraldine O.Sullivan Coyne, Lihua Wang, Jennifer Zlott, Lamin Juwara, Joseph M. Covey
Cancer Chemotherapy and Pharmacology. 2020-04-20
52 citations
Successful Therapy of Convoluted T-Lymphoblastic Lymphoma in the Adult
Alexandra M. Levine, Stephen J. Forman, Paul R. Meyer, Stephen C. Koehler, Howard A. Liebman
Blood. 1983-01-01

Press Mentions

Three US Navy Aircraft Carriers Are Patrolling the Pacific Ocean at the Same Time. And China's Not HappyJune 15th, 2020
Brain Functional MRI in Older Women with Breast Cancer (Brain fMRI-BC) (Brain fMRI-BC)November 25th, 2013